Navigating the transition from research to clinical-scale cell therapy manufacture

Steven Feldman, Johannes Fruehauf, Mary Ann Santos

22 May 2025

Register

Turbocharging pDNA production: a case study on optimization through novel technologies

Xiangming Gu, Lucas Smith

20 May 2025

Register

Flow with confidence: innovations that foster flexibility and scale in closed-system manufacturing

Nik Ekman

01 May 2025

Register

Safety assays for quality control of ATMPs: improved mycoplasma detection for cell-based biotherapeutics

Jens Björkman, Andreas Hecker

30 April 2025

Watch

Manufacturing Quality Control for Plasmid DNA Critical Starting Materials

A Frazer, L R. Salvitti, S Lovatt et al

29 April 2025

Watch

Optimizing iPSC therapies: strategies for safe, cost-effective, and scalable manufacturing

K Bruce, K Bharti, I Barbaric et al

23 April 2025

Watch

Harnessing AI and omics for next-generation gene therapy manufacturing

Richard Braatz, Irene Rombel

14 April 2025

Interview

Navigating analytical and regulatory hurdles in early-phase clinical cell therapy development

Vaibhav Patel

10 April 2025

Interview

The reality of automation in CGT—Why closed systems matter: INFOGRAPHIC

09 April 2025

Infographic

CAR-T manufacturing intensification: the next wave of CAR-T commercialization

A Bersenev, E Kleiren, J Knighton et al

03 April 2025

Innovator Insight

Strategies for streamlined manufacturing and analytics in CGT development

Laura Mueller, Silvio Weber, Dirk Windgassen

01 April 2025

Watch

Producing MSC-derived cell therapies: workflows, technologies, and case studies

I Malaspina, S Mei, T Ting et al

28 March 2025

Expert Roundtable

Advancing cell therapy: Optimizing the cell culture environment for high-quality manufacture of suspension and adherent cells

Mindy Miller, Nathan Frank

27 March 2025

Watch

Salt-tolerant endonucleases, the benefits for viral vector manufacturing and a comparison of two marketed enzymes

Marc Struhalla, Svenja Michalek

26 March 2025

Innovator Insight

Transforming cell therapy manufacturing: smart automation & genetic modification for scalable success

Peter Szaraz, Tessel Hammink

20 March 2025

Watch

Ensuring compliance through collaboration: managing raw material changes in cell and gene therapy regulatory filings

Kasey Kime, Xiao Peng

20 March 2025

Innovator Insight

Streamlining the supply chain: insights on raw material sourcing and quality by design

Lara Silverman

19 March 2025

Interview

GMP or not? Understanding raw material quality grades and requirements for ATMP manufacturing

Lili Belcastro, Basak Clements, Claire Wartel

18 March 2025

Watch

Driving innovation to advance allogeneic cell therapies through manufacturing platform development

Jason Dowd

18 March 2025

Interview

Next-gen immunotherapy: a guide for CGT developers

Alex Sargent

11 March 2025

Watch

Choosing the best path to patients: how to decide between in-house and outsourced iPSC therapy development and manufacturing

Laura Koivusalo, Anni Mörö, Ross Macdonald

11 March 2025

Commentary